At the end of the latest market close, QIAGEN N.V. (QGEN) was valued at $49.48. In that particular session, Stock kicked-off at the price of $50.78 while reaching the peak value of $53.01 and lowest value recorded on the day was $50.63. The stock current value is $52.97.
Recently in News on December 8, 2020, QIAGEN Increases Outlook for 2020 and 2021. Full-year 2020 net sales now expected to grow approximately 22% CER and adjusted EPS to reach $2.13-2.14 CER . You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
QIAGEN N.V. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $55.27 on 10/12/20, with the lowest value was $32.97 for the same time period, recorded on 02/04/20.
QIAGEN N.V. (QGEN) full year performance was 27.95%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, QIAGEN N.V. shares are logging -4.16% during the 52-week period from high price, and 75.22% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $30.23 and $55.27.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3920006 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the QIAGEN N.V. (QGEN) recorded performance in the market was 56.72%, having the revenues showcasing 6.90% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.12B, as it employees total of 5200 workers.
QIAGEN N.V. (QGEN) in the eye of market guru’s
During the last month, 0 analysts gave the QIAGEN N.V. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 49.84, with a change in the price was noted +4.64. In a similar fashion, QIAGEN N.V. posted a movement of +9.60% for the period of last 100 days, recording 1,208,309 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for QGEN is recording 0.66 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.52.
QIAGEN N.V. (QGEN): Stocks Technical analysis and Trends
Raw Stochastic average of QIAGEN N.V. in the period of last 50 days is set at 76.86%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 99.42%. In the last 20 days, the company’s Stochastic %K was 84.06% and its Stochastic %D was recorded 79.34%.
If we look into the earlier routines of QIAGEN N.V., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 56.72%. Additionally, trading for the stock in the period of the last six months notably improved by 23.27%, alongside a boost of 27.95% for the period of the last 12 months. The shares increased approximately by 10.72% in the 7-day charts and went down by 14.93% in the period of the last 30 days. Common stock shares were driven by 6.90% during last recorded quarter.